Gurnee, ILNCT07710820Now EnrollingIRB Ready

Smoking Clinical Trial in Gurnee, IL

Access cutting-edge smoking treatment through this clinical trial at a research site in Gurnee. Study-provided care at no cost to qualified participants.

Sponsored by RAI Services Company

Quick Self-Assessment

See if you qualify for this Gurnee location

Preparing your pre-screening questions…

Expert Care in Gurnee

Access smoking specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related smoking treatment provided free

Apply for This Gurnee Location

Check if you qualify for this smoking clinical trial in Gurnee, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Gurnee

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Gurnee site if eligible
  4. 4Begin participation

About This Smoking Study in Gurnee

The goal of this study is to evaluate the rate of end of study complete cigarette reduction in health adult consumers of cigarettes when given access to a heated tobacco product (HTP). The primary study objective is to evaluate the impact of access to HTP Device 1 or HTP Device 2 and a single stick variant on the rate of final 7-day abstinence from smoking cigarettes among U.S. adult smokers at the end of a 3-month study period.

Sponsor: RAI Services Company

Who Can Participate

Inclusion Criteria

Able to read, understand, and are willing to sign an Informed Consent Form (ICF) and complete questionnaires written in English.
Generally healthy male or female, between 21 and 65 years of age, inclusive, at the time of consent, verified with government-issued identification.
All female (assigned at birth) candidate participants who agree to take the pregnancy test on site and receive a negative result, and who affirm at the SEV that they are not pregnant or intending to become pregnant. Note: Participants who identify as "intersex" or "unknown" during screening, will be required to take a pregnancy test if they wish to take one.
Currently smoke at least five combustible cigarettes on smoking days in the past 30 days.
Smoke combustible cigarettes on 15 or more of the past 30 days.
Smoked at least 100 factory-made filtered menthol and/or non-menthol combustible cigarettes in their lifetime prior to the Site Enrollment Visit.
Must indicate a neutral/positive intention to use at least one stick variant at the Site Enrollment Visit.
Own a smartphone (iOS or Android) with internet access to download a study application to access surveys and the capability to receive notifications.
Agree to participate in the study and to abide by the study restrictions and requirements, as described in the ICF.
Must try all four stick variants during the 1-week product trial period.
Must indicate a neutral/positive intention to use at least one stick variant following the product trial period.

Exclusion Criteria

Female participants who are pregnant or breastfeeding or planning to become pregnant or start breastfeeding within the next 6 months based on self-report.
Male participants who self-report they are not willing to use a barrier method of contraception (e.g., a condom with spermicide) or refrain from donating sperm from the time of the signing of the ICF until the end of the study, unless they have undergone a vasectomy or are abstinent from heterosexual intercourse, or their female partner was not able to bear children.
Female participants who self-report not using adequate methods to prevent pregnancy.
Persons with pacemakers or other embedded electronic medical devices fitted.
Participants who self-report having an unstable heart condition, severe hypertension, or diabetes.
Individuals who respond with 'Poor' or 'Don't know' to general physical or mental health.
Participants who have used electronic nicotine delivery system (ENDS), nicotine pouches, HTP or smokeless tobacco (i.e., chewing tobacco, snus, or snuff) products, other combustible tobacco/nicotine products, and other oral nicotine products (tablets, gums, and lozenges) on 5 or more days in the past 30 days.
Participants who have used a nicotine replacement therapy (NRT) product or a prescription drug to help stop smoking (e.g., varenicline, bupropion) in the past 30 days.
Employee of a company that manufactures tobacco or HTPs.
Persons who are personally, have household members, or have close family or friends in litigation with a company that manufactures tobacco or HTPs.
Have taken part in a tobacco/nicotine research study in the past 30 days.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Gurnee?

Yes, this clinical trial (NCT07710820) has an active research site in Gurnee, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Smoking Treatment Options in Gurnee, IL

If you're searching for smoking treatment options in Gurnee, IL, this clinical trial (NCT07710820) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Gurnee research site is actively enrolling participants for this clinical trial. You'll receive care from experienced smoking specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in Gurnee?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Gurnee, IL